Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUDOPRESS: Fluoxetine and Dolutegravir in HIV-Associated Depression
NCT07110831Phase 4Not yet recruiting
- Start
- Aug 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in major depressive disorder (MDD). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07110831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07110831.